GetPortalImpactFactorByIdResp(projectId=1, id=c8e87245, cover=https://img.medsci.cn/images/journal/cover/2021/Vvv_202109271314387210.jpg, fullname=Cellular & Molecular Immunology, abbr=CELL MOL IMMUNOL, pyear=2004, frequence=Bimonthly, articleNumbers=575, citedSelf2015=6.9, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均3.08月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1672-7681, greenSci=https://www.greensci.net/search?kw=1672-7681, scijournal=https://www.scijournal.org/impact-factor-of-CELL-MOL-IMMUNOL.shtml, medsciHotlightString=null, medsciHotlightRealtime=7.506, medsciHotlight=11.903, medsciHotlight5year=13.1673, citescore=0.0, hIndex=81, impactFactor=24.1, orgnization=Nature Publishing Group, orgnizationUrl=https://www.nature.com, country=United States, countryCn=美国, isOa=3, isOaString=部分OA, sciScie=Science Citation Index Expanded|Current Contents - Life Sciences|BIOSIS Previews, bigclassCas=医学 1区[Top], smallclassCas=, website=https://www.nature.com/cmi/index.html, websiteHits=16353, guideForAuthor=https://www.nature.com/cmi/authors-and-referees/authors, guideForAuthorHits=213, submitWebsite=https://mts-cmi.nature.com/cgi-bin/main.plex, submitWebsiteHits=6249, content=<h1 class="small-space-below">Aims & Scope</h1> <p class="norm"><em>Cellular & Molecular Immunology</em> is a monthly journal from the Chinese Society of Immunology and the University of Science and Technology of China. Covering both basic immunology research and clinical applications, <em>Cellular & Molecular Immunology</em> provides the latest information and advancements in our understanding of the immunological response of the host, both <span class="i">in vitro</span> and <span class="i">in vivo</span>.</p> <p class="norm">The journal publishes Articles, Review Articles, Mini Reviews and Short Communications and Correspondences in all areas of cellular and molecular immunology, including but not limited to:</p> <ul class="info"> <li>clinical immunology</li> <li>comparative immunology</li> <li>immunobiology</li> <li>immunogenetics</li> <li>immunological techniques</li> <li>immunopathology</li> <li>immunopharmacology</li> <li>infection immunology</li> <li>neuroimmunology</li> <li>transplantation immunology</li> <li>tumor immunology</li> <li>veterinary immunology</li> </ul> <p class="norm">As China's first English-language immunology journal,<em> <span class="journalname">Cellular & Molecular Immunology</span> </em>is designed to serve both the Chinese and international communities as a vehicle to rapidly disseminate the latest studies in this field. The journal welcomes submissions that explore novel ideas or un- or contra-orthodox approaches, as long as they are underpinned by conventional scientific practice and present falsifiable hypotheses that are tested with empirical methods and evidence.</p> <p class="norm">Manuscripts must provide evidence that can be critically evaluated, and where applicable:</p> <ul class="info"> <li>define disorders and clinical symptoms by standard clinical terms (e.g. allergy, asthma, lupus, etc.)</li> <li>deem results 'significant' only using standard statistical methods in biological effects/outcomes studies</li> <li>use consistent and defined amounts and mixtures of herbal formulas, or use purified monomer extracts.</li> </ul> <p class="norm">Terms that may be ambiguous to the broad audience of the journal should be clearly defined within the manuscript.</p> <p><em>Citations</em><br />2 Year Impact Factor (2021): <strong>22.100</strong>*<br />5 Year Impact Factor (2021): <strong>17.702</strong>*<br />JCR Rank*: <strong>6/162(Q1) Immunology</strong><br />Immediacy Index: <strong>5.796</strong>*<br />Eigenfactor Score: <strong>0.01977</strong>*<br />Article Influence Score: <strong>4.342</strong>*<br />Journal Citation Indicator: <strong>1.63*</strong><br />SJR: <strong>2.960</strong><br />SNIP: <strong>2.080</strong></p> <p><em>Access</em><br />Total webpage views, 2022: <strong>883,010</strong></p> <p><em>Usage</em><br /><strong>1,463,111</strong> Downloads (in 2022)<br /><strong>6,156</strong> Altmetric mentions (2022)</p> <p><em>*2021 Journal Citation Reports (Clarivate, 2022)</em></p> <h2>Abstracted/indexed in</h2> <ul> <li>BIOSIS​</li> <li>CAS</li> <li>Crossref</li> <li>MEDLINE</li> <li>PubMed/PMC</li> <li>Science Citation Index Expanded</li> <li>SCImago</li> <li>SCOPUS</li> </ul> <h2>ISSN and eISSN</h2> <p>The international standard serial number (ISSN) for <em>Cellular & Molecular Immunology</em> is 1672-7681, and the electronic international standard serial number (eISSN) is 2042-0226.</p>, totalCites=13869, brief=CELL MOL IMMUNOL杂志医学行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=生化与分子生物学" >生化与分子生物学</a></strong>”子行业的级别不明杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=CELL MOL IMMUNOL杂志级别还可以，但是相对来说，比较冷门，关注人数偏少，有些可能是国内不太熟悉，但该杂志在国际仍然有相当知晓度的。因为缺少中国人投稿，稿源可能未必丰富，发表有可能有很大的机会哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=c8e87245'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=205, tagName=免疫, createdHits=2), ImpactFactorTagDto(id=120, tagName=免疫学, createdHits=1), ImpactFactorTagDto(id=43768, tagName=basic immun resaech, createdHits=1), ImpactFactorTagDto(id=45905, tagName=immunopharmacology, createdHits=1), ImpactFactorTagDto(id=5209, tagName=炎症因子, createdHits=1), ImpactFactorTagDto(id=120, tagName=免疫学, createdHits=1), ImpactFactorTagDto(id=65712, tagName=免疫药理学, createdHits=1), ImpactFactorTagDto(id=57973, tagName=临床免疫学, createdHits=1), ImpactFactorTagDto(id=475889, tagName=免疫遗传学, createdHits=1), ImpactFactorTagDto(id=477198, tagName=免疫遗传, createdHits=1), ImpactFactorTagDto(id=43004, tagName=移植免疫, createdHits=1), ImpactFactorTagDto(id=2892, tagName=免疫调节, createdHits=1), ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=3.76), GetImpactFactorCiteScoreListResponse(year=2017, citescore=5.13), GetImpactFactorCiteScoreListResponse(year=2018, citescore=5.23), GetImpactFactorCiteScoreListResponse(year=2019, citescore=11.8), GetImpactFactorCiteScoreListResponse(year=2020, citescore=0.0)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=14.101), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=14.313), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=11.174), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=9.452), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=7.506)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Infectious Diseases , rank=14/272), GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Immunology and Allergy , rank=25/188), GetImpactFactorCiteScoreGradeResponse(smallClass=Immunology and Microbiology - Immunology , rank=32/198)], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1672-7681[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=CELLULAR & MOLECULAR IMMUNOLOGY[ta], article_number=163, article_number_cn=77, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)